Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48,507,463
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
18,418,726
-
Shares change
-
-750,453
-
Total reported value, excl. options
-
$316,117,290
-
Value change
-
-$12,884,754
-
Number of buys
-
17
-
Number of sells
-
-17
-
Price
-
$17.16
Significant Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q3 2021
46 filings reported holding HOWL - Werewolf Therapeutics, Inc. - Common Stock as of Q3 2021.
Werewolf Therapeutics, Inc. - Common Stock (HOWL) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,418,726 shares
of 48,507,463 outstanding shares and own 37.97% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4,291,881 shares), MPM ASSET MANAGEMENT LLC (4,284,172 shares), BioImpact Capital LLC (2,388,011 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1,752,787 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (985,448 shares), SPHERA FUNDS MANAGEMENT LTD. (688,475 shares), Avidity Partners Management LP (625,120 shares), Soleus Capital Management, L.P. (563,396 shares), PFM Health Sciences, LP (400,000 shares), and BlackRock Inc. (369,961 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.